Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca    AZN   GB0009895292

ASTRAZENECA

(AZN)
SummaryQuotesChartsNewsRatingsCalendarCompany 
Business Summary
Logo AstraZeneca
AstraZeneca is one of the world's leading pharmaceutical groups. Net sales break down by treatment area as follows:

- cardiovascular and metabolic diseases (32.3%);

- respiratory diseases (20.9%);

- oncology (17.9%);

- other (18.5%): inflammatory and autoimmune diseases, neurological diseases, gastrointestinal and infectious diseases.

The remaining sales (10.4%) concern primarily research and study services provided for third parties.

Net sales are distributed geographically as follows: the United Kingdom (2.4%), Continental Europe (23.4%), Americas (37.1%) and Africa/Asia/Australia (37.1%).

Number of employees : 64 400 people.
Sales per Businesses
20172018Delta
GBP (in Million)%GBP (in Million)%
Cardiovascular, Renal & Metabolism5,64232.3%5,03230.4% -10.81%
Respiratory3,65420.9%3,68322.2% +0.79%
Other Diseases3,22718.5%2,55015.4% -20.99%
Oncology3,12517.9%4,52127.3% +44.68%
Externalisation Revenue1,79610.3%780.714.7% -56.53%
Sales per Regions
20172018Delta
GBP (in Million)%GBP (in Million)%
United States5,17629.7%5,43032.8% +4.9%
United Kingdom2,51614.4%1,79210.8% -28.76%
China2,29513.2%2,83317.1% +23.48%
Japan1,6879.7%1,4648.8% -13.2%
Other Continental Europe1,1746.7%983.955.9% -16.19%
Other Asia, Africa and Australasia937.245.4%980.955.9% +4.66%
Sweden653.823.7%357.732.2% -45.29%
Other Americas628.193.6%604.473.6% -3.78%
France544.333.1%462.732.8% -14.99%
Germany420.092.4%443.982.7% +5.69%
Italy399.122.3%319.481.9% -19.95%
Canada374.282.1%362.232.2% -3.22%
Spain347.102%296.981.8% -14.44%
Australia292.741.7%234.741.4% -19.81%
Managers
NameAgeSinceTitle
Pascal Soriot20182012Chief Executive Officer & Executive Director
Leif Johansson-2012Non-Executive Chairman
Pam Cheng20182015Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer20182013Chief Financial Officer & Executive Director
Marcus Wallenberg-1999Independent Non-Executive Director
Graham Chipchase-2019Senior Independent Non-Executive Director
Geneviéve B. Berger, Dr.20182012Independent Non-Executive Director
Philip Arthur John Broadley-2017Non-Executive Director
Nazneen Rahman, Dr.20182017Non-Executive Director
Sherilyn S. McCoy20182017Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 1,311,894,438 1,307,385,873 99.7% 0 0.0% 99.7%
Shareholders
NameEquities%
Investor AB (Investment Company) 144,008,120 11.0%
Capital Research & Management Co. (World Investors) 54,590,782 4.16%
BlackRock Investment Management (UK) Ltd. 44,717,199 3.41%
Wellington Management Co. LLP 41,540,715 3.17%
The Vanguard Group, Inc. 38,043,152 2.90%
Legal & General Investment Management Ltd. 29,153,297 2.22%
Norges Bank Investment Management 28,709,000 2.19%
BlackRock Fund Advisors 22,251,756 1.70%
Fidelity Management & Research Co. 21,573,000 1.64%
Dodge & Cox 16,884,000 1.29%
Holdings
NameEquities%Valuation
Astrazeneca Pharma India Ltd (506820) 18,750,00075.0%494,630,250 USD
Moderna, Inc. (MRNA) 25,499,3257.72%401,104,382 USD
Swedish Orphan Biovitrum (SOBI) 24,193,0928.13%400,636,152 USD
Innate Pharma (IPH) 6,260,5009.76%41,676,524 USD
PhaseBio Pharmaceuticals, Inc. (PHAS) 3,004,55410.5%25,959,347 USD
Circassia Pharmaceuticals plc (CIR) 71,081,21718.9%16,144,677 USD
Entasis Therapeutics Holdings Inc. (ETTX) 2,164,85516.5%16,019,927 USD
2947.12%0 USD
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, OMX Stockholm 30, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  AZN:LN
- Reuters Code :  AZN.L
- Datastream Code :  AZN
Company contact information
AstraZeneca
1 Francis Crick Avenue
CB2 0AA Cambridge, Cambridgeshire
United Kingdom

Phone : +44 (0)20 3749 5000
Fax : +44 (0)20 7604 8151
Internet : http://www.astrazeneca.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of AstraZeneca
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ASTRAZENECA PLC14.74%115 078
JOHNSON & JOHNSON0.01%346 602
ROCHE HOLDING AG18.02%248 022
MERCK AND COMPANY10.38%215 942
PFIZER-17.27%199 726
NOVARTIS14.95%199 287
NOVO NORDISK AS17.25%121 422
AMGEN3.15%120 420
SANOFI8.45%113 522
ABBVIE-20.13%108 861
GLAXOSMITHKLINE12.33%105 134
ELI LILLY AND COMPANY-6.36%99 196
BRISTOL-MYERS SQUIBB COMPANY-0.71%84 422
CELGENE CORPORATION56.92%71 278
BAYER AG7.69%67 206
ALLERGAN PLC26.51%55 467
TAKEDA PHARMACEUTICAL COMPANY LIMITED2.76%53 412
JIANGSU HENGRUI MEDICINE CO.57.35%51 811
CHUGAI PHARMACEUTICAL CO., LTD.31.07%40 847
DAIICHI SANKYO COMPANY, LIMITED90.31%38 903
ASTELLAS PHARMA INC.14.84%27 554
Connections : AstraZeneca